Association of non-invasive prenatal testing and chromosomal microarray analysis for prenatal diagnostics

Gynecological Endocrinology

Volumn 30, Issue , 2014, Pages 13-16

  Korostelev, S ^a   Totchiev, G ^b   Kanivets, I ^c   Gnetetskaya, V ^d  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

^c Filatov Children Hospital   (Russian Federation)

^d Mother and Child Group of Companies   (Russian Federation)

Author keywords

Chromosomal microarray analysis; Non invasive prenatal test; Prenatal diagnostics

Indexed keywords

ADULT; AMNION CELL; ANEUPLOIDY; ARTICLE; CHROMOSOMAL MICROARRAY ANALYSIS; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; KARYOTYPING; MICROARRAY ANALYSIS; MONOSOMY; NON INVASIVE PRENATAL TESTING; NON INVASIVE PROCEDURE; NORMAL HUMAN; PREGNANT WOMAN; PRENATAL SCREENING; TRISOMY 13; TRISOMY 18; TRISOMY 21; ALGORITHM; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ABERRATION; EMBRYOLOGY; GENETICS; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME; Y CHROMOSOME;

ADULT; ALGORITHMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; HUMANS; MICROARRAY ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84907045604     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.945770     Document Type: Article

References (18)

1. Wapner R, Thom E, Simpson JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-13.
2. Snijders RJ, Noble P, Sebire N, et al. UK Multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352: 343-6.
3. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7-15.
4. Souka AP, Von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192:1005-21.
5. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013;122: 1374-7.
6. Srebniak MI, Boter M, Oudesluijs GO, et al. Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalities. Mol Cytogenet 2012;5:14.
7. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367: 2175-84.
8. Fiorentino F, Napoletano S, Caiazzo F, et al. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities. Eur J Hum Genet 2013;21:725-30.
9. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-8.
10. Bianchi DW, Platt LD, Goldberg JD. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
11. Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first trimester population. Am J Obstet Gynecol 2012;207:374.e1-6.
12. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y using targeted sequencing of polymorphic loci. Prenat Diag 2012;32: 1233-41.
13. Larion S, Warsof SL, Romary L, et al. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures. Obstet Gynecol 2014;123:1303-10.
14. Rabinowitz M, Savage M, Pettersen B, et al. Noninvasive cell-free DNA-based prenatal detection of microdeletions using single nucleotide polymorphism-targeted sequencing. Obstet Gynecol 2014;123 Suppl 1:167S.
15. Bilardo CM, Muller MA, Pajkrt E, et al. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstetr Gynecol 2007;30:11-18.
16. Bilardo CM, Timmerman E, Pajkrt E, Van Maarle M. Increased nuchal translucency in euploid fetuses-what should we be telling the parents? Prenatal Diagnosis 2010;30:93-102.
17. Leung TY, Vogel I, Lau TK, et al. Identication of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol 2011;38:314-19.
18. Nicolaides KH, Syngelaki A, Gil M, et al. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diag Special Issue: Noninvasive Prenatal Testing Using Maternal Plasma DNA: Part I 2013;33:575-9.